DrugInformations.org

A topical spray reduced pain by 34% in children undergoing intravenous procedures, such as injections and tube insertions (cannulation), compared with a placebo group. The findings from this double-blind, randomized controlled trial have clinical implications, write the researchers. “The vapocoolant spray that we used provided quick and effective reduction of pain due to intravenous cannulation without delaying the procedure,” state Dr. William Splinter and colleagues.

More: continued here

No Comments »

More than half of all people with chronic pain are smokers, and research at suggests that cigarette smoking may make chronically painful conditions worse. In a recent study published in the Journal of Abnormal Psychology, Moffitt researchers found for the first time that smokers often have greater urges to smoke and smoke more cigarettes when they experience pain.

More: continued here

No Comments »

The Chronic Pain Policy Coalition (CPPC), established to promote better treatment for the 7.8 million who suffer from long-term chronic pain such as severe back pain or depression, is calling for a national chronic pain treatment framework for England in the light of the Darzi review into the future of the NHS.

More: continued here

No Comments »

Orexo AB (OMX: ORX), the Swedish pharmaceutical company, announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of Rapinyl, for breakthrough cancer pain. ProStrakan Group plc, the international speciality pharmaceutical is Orexo´s exclusive partner for sales and marketing of Abstral/Rapinyl in Europe.

More: continued here

No Comments »

Troublesome sports injuries are the target of PainEaze Sport, a new roll-on and spray range launched by the company behind the already popular original pain relief formula - PainEaze. With more than 10 million recreational sports injuries occurring every year, the products have been created to aid sufferers, by calming inflammation in damaged muscles and joints whilst providing fast acting pain relief through its blend of 100 per cent natural ingredients.

More: continued here

No Comments »

About 20% of heart attack patients experience angina (chest pain) one year after the major cardiac event, according to researchers who have published a new study in the June 23 issue of Archives of Internal Medicine. In both inpatient and outpatient settings, a primary goal of care after myocardial infarction (MI), commonly known as heart attack, is to the episodic chest pain known as angina.

More: continued here

No Comments »

What’s the biggest pain in your life? Credit card debt? High gas prices? While these problems are extremely bothersome, a new survey from the makers of DR. SCHOLL’S® reveals that the physical pain suffered by people with knee and lower back pain is also at the top of the list. The survey shows that knee and lower back pain pervade many aspects of respondents’ lives - and that’s only the beginning of the story.

More: continued here

No Comments »

The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli Lilly and Company (NYSE: LLY) announced. Cymbalta is the first serotonin- norepinephrine reuptake inhibitor with proven efficacy for reducing pain in patients with fibromyalgia. The fibromyalgia indication represents the second FDA-approved use for Cymbalta for a pain disorder, demonstrating the medication’s analgesic effect.

More: continued here

No Comments »

The general anesthesia that puts patients into unconscious sleep so they do not feel surgical pain can increase the discomfort they feel once they wake up, say researchers from Georgetown University Medical Center. They say their findings, the first to scientifically explain what has been anecdotally observed in the clinic, may lead to wider use of the few anesthetics that don’t have this side effect, or to the development of new ones.

More: continued here

No Comments »

Pain is the most common complaint leading patients to seek medical care and much of it is chronic, lasting 3 months or longer. According to an extensive review of clinical research in a new report from Pain Treatment Topics, inadequate vitamin D intake has been linked to a long list of chronic painful maladies, including bone and joint pain of various types, muscle pain, fibromyalgia syndrome, rheumatic disorders, osteoarthritis, and other complaints.

More: continued here

No Comments »